SymPowerco Corp. (Public, PINK:SYMW) StocksHaven Investments analyzes one of the most undervalued alternative energy plays, which in the near future may find itself alongside the predominant players within the Fuel Cell & Hybrid Power Systems Research & Development sector. SymPowerco is an energy technology company focused on the design and development of clean and practical [...]
Somaxon Pharmaceuticals, Inc. (Public, NASDAQ:SOMX) StocksHaven Investments profiles one of the most promising biomedical pharmaceutical company involved with a PDUFA with regards to a drug which could quite possibly revolutionize the treatment for insomnia, a condition affecting over 70 million Americans. The company has been making waves the past few months as investors and institutions [...]
Hard to Treat Diseases, Inc. (Public, PINK:HTDS) With the upcoming flu season upon us (considered between October and May with the peak of the season falling between late December and March), StocksHaven Investments highlights one of the most undervalued pink sheet penny biomedical stocks available, which not only tackles influenza treatments, but also many other [...]
The following article was written and contributed by a highly regarded investor and member within the StocksHaven Investments community, Jeff Lawson: With the recent passage and signing of the Credit Card Accountability, Responsibility, and Disclosure Act of 2009 (the Credit CARD Act), some changes will be coming to a credit card near you in the [...]
TerreStar Corporation (Public, NASDAQ:TSTR) TerreStar Corporation’s recent launch of TerreStar-1, world’s largest communication satellite is progressing nicely through the critical stages, well on its way to reaching a geostationary orbit. TerreStar 1 will be maneuvered into a circular geostationary orbit eventually parking itself above the equator at 111 degrees West longitude to cover the United [...]
Elan Corporation (Public, NYSE:ELN) About Elan Corporation, plc (Elan) is a neuroscience-based biotechnology company. Its principal research and development, manufacturing and marketing facilities are located in Ireland and the United States. Elan’s operations are organized into two business units: Biopharmaceuticals and Elan Drug Technologies (EDT). Biopharmaceuticals engages in research, development and commercial activities primarily in [...]
TerreStar Corporation (Public, NASDAQ:TSTR) With the recent launching of TerreStar-1, TerraStar Corporation looks to break through and become a leader in the communications industry. AT&T Mobility along with TerreStar Corporation will market a hybrid prototype terrestrial/satellite hand set yet this year. The technology will allow the new hand set to operate on ground-based phone networks. [...]
Aradigm Corporation (Public, OTC:ARDM) Aradigm is a company with a lot of potential positive long-term gains, especially with regards to its product pipeline involving the inhaled Cipro product (ILCH) for BE and CF, however the short-term play is a very different story. This company lacks visibility and the ability to fully utilize press release syndication [...]
Access Pharmaceuticals, Inc. (OTC:ACCP) Many investors have raised concerns with regards to Access Pharmaceuticals being on the OTC. Indeed more than half the time companies which are not listed on a major exchange tend to lie, cheat and do just about anything possible in order to stimulate investor demand. They will reach out to stock [...]
